MicroRNAs in pulmonary arterial hypertension: Pathogenesis, diagnosis and treatment

Journal of the American Society of Hypertension

Volumn 9, Issue 3, 2015, Pages 221-234

  Bienertova Vasku, Julie ^a   Novak, Jan ^a   Vasku, Anna ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Hypoxia; lungs; non coding RNAs; vascular remodeling

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 124; MICRORNA 143; MICRORNA 145; MICRORNA 150; MICRORNA 190; MICRORNA 204; MICRORNA 206; MICRORNA 21; MICRORNA 210; MICRORNA 27A; MICRORNA 328; MICRORNA 424; UNCLASSIFIED DRUG;

BIOGENESIS; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVIEW; RNA PROCESSING; SMOOTH MUSCLE FIBER; ANIMAL; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; MICRORNAS; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 84925243798     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2014.12.011     Document Type: Review

References (111)

1. J.S. Grant, K. White, M.R. Maclean, and A.H. Baker MicroRNAs in pulmonary arterial remodeling Cell Mol Life Sci 70 2013 4479 4494
2. N. Galie, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, and J.A. Barbera Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Respir J 34 2009 1219 1263
3. K.B. Lane, R.D. Machado, M.W. Pauciulo, J.R. Thomson, J.A. Phillips 3rd, and J.E. Loyd Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension Nat Genet 26 2000 81 84
4. R.D. Machado, M.W. Pauciulo, J.R. Thomson, K.B. Lane, N.V. Morgan, and L. Wheeler BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension Am J Hum Genet 68 2001 92 102
5. J.R. Thomson, R.D. Machado, M.W. Pauciulo, N.V. Morgan, M. Humbert, and G.C. Elliott Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family J Med Genet 37 2000 741 745
6. P.L. Jones, K.N. Cowan, and M. Rabinovitch Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease Am J Pathol 150 1997 1349 1360
7. S. Malenfant, A.S. Neyron, R. Paulin, F. Potus, J. Meloche, and S. Provencher Signal transduction in the development of pulmonary arterial hypertension Pulm Circ 3 2013 278 293
8. M. Rabinovitch Molecular pathogenesis of pulmonary arterial hypertension J Clin Invest 122 2012 4306 4313
9. S. Sakao, K. Tatsumi, and N.F. Voelkel Reversible or irreversible remodeling in pulmonary arterial hypertension Am J Respir Cell Mol Biol 43 2010 629 634
10. C.D. Cool, J.S. Stewart, P. Werahera, G.J. Miller, R.L. Williams, and N.F. Voelkel Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth Am J Pathol 155 1999 411 419
11. V.V. McLaughlin Looking to the future: a new decade of pulmonary arterial hypertension therapy Eur Respir Rev 20 2011 262 269
12. J. Gomez-Arroyo, S.J. Saleem, S. Mizuno, A.A. Syed, H.J. Bogaard, and A. Abbate A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects Am J Physiol Lung Cell Mol Physiol 302 2012 L977 L991
13. M.R. Nicolls, S. Mizuno, L. Taraseviciene-Stewart, L. Farkas, J.I. Drake, and A. Al Husseini New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis Pulm Circ 2 2012 434 442
14. K.H. Hong, Y.J. Lee, E. Lee, S.O. Park, C. Han, and H. Beppu Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension Circulation 118 2008 722 730
15. N.F. Voelkel, R.M. Tuder, K. Wade, M. Hoper, R.A. Lepley, and J.L. Goulet Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats J Clin Invest 97 1996 2491 2498
16. M.H. Xu, Y.S. Gong, M.S. Su, Z.Y. Dai, S.S. Dai, and S.Z. Bao Absence of the adenosine A2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice J Vasc Res 48 2011 171 183
17. J.G. Gomez-Arroyo, L. Farkas, A.A. Alhussaini, D. Farkas, D. Kraskauskas, and N.F. Voelkel The monocrotaline model of pulmonary hypertension in perspective Am J Physiol Lung Cell Mol Physiol 302 2012 L363 L369
18. F.F. Kirigin, K. Lindstedt, M. Sellars, M. Ciofani, S.L. Low, and L. Jones Dynamic microRNA gene transcription and processing during T cell development J Immunol 188 2012 3257 3267
19. Y. Lee, C. Ahn, J. Han, H. Choi, J. Kim, and J. Yim The nuclear RNase III Drosha initiates microRNA processing Nature 425 2003 415 419
20. B. Czech, and G.J. Hannon Small RNA sorting: matchmaking for Argonautes Nat Rev Genet 12 2011 19 31
21. E. Lund, S. Guttinger, A. Calado, J.E. Dahlberg, and U. Kutay Nuclear export of microRNA precursors Science 303 2004 95 98
22. M.T. Bohnsack, K. Czaplinski, and D. Gorlich Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs RNA 10 2004 185 191
23. R. Yi, Y. Qin, I.G. Macara, and B.R. Cullen Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs Genes Dev 17 2003 3011 3016
24. Y. Zeng, and B.R. Cullen Structural requirements for pre-microRNA binding and nuclear export by Exportin 5 Nucleic Acids Res 32 2004 4776 4785
25. Y. Lee, K. Jeon, J.T. Lee, S. Kim, and V.N. Kim MicroRNA maturation: stepwise processing and subcellular localization EMBO J 21 2002 4663 4670
26. B. Mallick, and Z. Ghosh Probing evolutionary biography of microRNAs and associated factors Curr Genomics 13 2012 144 152
27. S.R. Joshi, J.M. McLendon, B.S. Comer, and W.T. Gerthoffer MicroRNAs-control of essential genes: Implications for pulmonary vascular disease Pulm Circ 1 2011 357 364
28. A.S. Flynt, and E.C. Lai Biological principles of microRNA-mediated regulation: shared themes amid diversity Nat Rev Genet 9 2008 831 842
29. J. Brennecke, A. Stark, R.B. Russell, and S.M. Cohen Principles of microRNA-target recognition PLoS Biol 3 2005 e85
30. S. Albinsson, A. Skoura, J. Yu, A. DiLorenzo, C. Fernandez-Hernando, and S. Offermanns Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function PloS One 6 2011 e18869
31. S. Albinsson, Y. Suarez, A. Skoura, S. Offermanns, J.M. Miano, and W.C. Sessa MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function Arterioscler Thromb Vasc Biol 30 2010 1118 1126
32. P. Caruso, M.R. MacLean, R. Khanin, J. McClure, E. Soon, and M. Southgate Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline Arterioscler Thromb Vasc Biol 30 2010 716 723
33. V.N. Parikh, R.C. Jin, S. Rabello, N. Gulbahce, K. White, and A. Hale MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach Circulation 125 2012 1520 1532
34. J. Sarkar, D. Gou, P. Turaka, E. Viktorova, R. Ramchandran, and J.U. Raj MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration Am J Physiol Lung Cell Mol Physiol 299 2010 L861 L871
35. S. Yang, S. Banerjee, A. Freitas, H. Cui, N. Xie, and E. Abraham miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling Am J Physiol Lung Cell Mol Physiol 302 2012 L521 L529
36. B.Y. Kang, K.K. Park, D.E. Green, K.M. Bijli, C.D. Searles, and R.L. Sutliff Hypoxia mediates mutual repression between microRNA-27a and PPARgamma in the pulmonary vasculature PloS One 8 2013 e79503
37. E. Mogilyansky, and I. Rigoutsos The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease Cell Death Differ 20 2013 1603 1614
38. H.L. Yan, G. Xue, Q. Mei, Y.Z. Wang, F.X. Ding, and M.F. Liu Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis EMBO J 28 2009 2719 2732
39. K.A. O'Donnell, E.A. Wentzel, K.I. Zeller, C.V. Dang, and J.T. Mendell c-Myc-regulated microRNAs modulate E2F1 expression Nature 435 2005 839 843
40. M.K. Steiner, O.L. Syrkina, N. Kolliputi, E.J. Mark, C.A. Hales, and A.B. Waxman Interleukin-6 overexpression induces pulmonary hypertension Circ Res 104 2009 236 244 28p following 44
41. M. Brock, M. Trenkmann, R.E. Gay, B.A. Michel, S. Gay, and M. Fischler Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway Circ Res 104 2009 1184 1191
42. A. Taguchi, K. Yanagisawa, M. Tanaka, K. Cao, Y. Matsuyama, and H. Goto Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster Cancer Res 68 2008 5540 5545
43. Y. Jin, B. Chen, T.E. Tipple, and L.D. Nelin Arginase II is a target of miR-17-5p and regulates miR-17-5p expression in human pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol 307 2014 L197 L204
44. K. Kang, X. Peng, X. Zhang, Y. Wang, L. Zhang, and L. Gao MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells J Biol Chem 288 2013 25414 25427
45. D. Wang, H. Zhang, M. Li, M.G. Frid, A.R. Flockton, and B.A. McKeon MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts Circ Res 114 2014 67 78
46. T. Song, X. Zhang, C. Wang, Y. Wu, W. Cai, and J. Gao MiR-138 suppresses expression of hypoxia-inducible factor 1alpha (HIF-1alpha) in clear cell renal cell carcinoma 786-O cells Asian Pac J Cancer Prev 12 2011 1307 1311
47. Y.M. Yeh, C.M. Chuang, K.C. Chao, and L.H. Wang MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1alpha Int J Cancer 133 2013 867 878
48. S. Li, Y. Ran, D. Zhang, J. Chen, and D. Zhu MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1 Biochem J 452 2013 281 291
49. A. Sen, S. Ren, C. Lerchenmuller, J. Sun, N. Weiss, and P. Most MicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting S100A1 PloS One 8 2013 e78684
50. A. Sen, P. Most, and K. Peppel Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunction FEBS Lett 588 2014 906 914
51. C.L. Bockmeyer, L. Maegel, S. Janciauskiene, J. Rische, U. Lehmann, and U.A. Maus Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression J Heart Lung Transplant 31 2012 764 772
52. K.R. Cordes, N.T. Sheehy, M.P. White, E.C. Berry, S.U. Morton, and A.N. Muth miR-145 and miR-143 regulate smooth muscle cell fate and plasticity Nature 460 2009 705 710
53. P. Caruso, Y. Dempsie, H.C. Stevens, R.A. McDonald, L. Long, and R. Lu A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples Circ Res 111 2012 290 300
54. C.J. Rhodes, J. Wharton, R.A. Boon, T. Roexe, H. Tsang, and B. Wojciak-Stothard Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension Am J Respir Crit Care Med 187 2013 294 302
55. S.S. Li, Y.J. Ran, D.D. Zhang, S.Z. Li, and D. Zhu MicroRNA-190 regulates hypoxic pulmonary vasoconstriction by targeting a voltage-gated K(+) channel in arterial smooth muscle cells J Cell Biochem 115 2014 1196 1205
56. A.R. Mackie, and K.L. Byron Cardiovascular KCNQ (Kv7) potassium channels: physiological regulators and new targets for therapeutic intervention Mol Pharmacol 74 2008 1171 1179
57. A. Courboulin, R. Paulin, N.J. Giguere, N. Saksouk, T. Perreault, and J. Meloche Role for miR-204 in human pulmonary arterial hypertension J Exp Med 208 2011 535 548
58. S. Jalali, G.K. Ramanathan, P.T. Parthasarathy, S. Aljubran, L. Galam, and A. Yunus Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation PloS One 7 2012 e46808
59. J. Yue, J. Guan, X. Wang, L. Zhang, Z. Yang, and Q. Ao MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1alpha/Fhl-1 pathway Lab Invest 93 2013 748 759
60. D. Gou, R. Ramchandran, X. Peng, L. Yao, K. Kang, and J. Sarkar miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia Am J Physiol Lung Cell Mol Physiol 303 2012 L682 L691
61. L. Guo, Z. Qiu, L. Wei, X. Yu, X. Gao, and S. Jiang The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-alpha1C Hypertension 59 2012 1006 1013
62. C.U. Andersen, O. Hilberg, S. Mellemkjaer, J.E. Nielsen-Kudsk, and U. Simonsen Apelin and pulmonary hypertension Pulmon Circ 1 2011 334 346
63. J. Kim, Y. Kang, Y. Kojima, J.K. Lighthouse, X. Hu, and M.A. Aldred An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension Nature Med 19 2013 74 82
64. T.P. Alastalo, M. Li, J. Perez Vde, D. Pham, H. Sawada, and J.K. Wang Disruption of PPARgamma/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival J Clin Invest 121 2011 3735 3746
65. Y.F. Chen, J.A. Feng, P. Li, D. Xing, Y. Zhang, and R. Serra Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling J Appl Physiol 100 2006 564 571
66. Y.F. Chen, and S. Oparil Endothelin and pulmonary hypertension J Cardiovasc Pharmacol 35 4 Suppl 2 2000 S49 S53
67. L. Iannone, L. Zhao, O. Dubois, L. Duluc, C.J. Rhodes, and J. Wharton MiRNA-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia Biochem J 462 2014 103 112
68. M. Gorospe, K. Tominaga, X. Wu, M. Fahling, and M. Ivan Post-transcriptional control of the hypoxic response by RNA-binding proteins and microRNAs Front Mol Neurosci 4 2011 7
69. D. Iliopoulos, S.A. Jaeger, H.A. Hirsch, M.L. Bulyk, and K. Struhl STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer Mol Cell 39 2010 493 506
70. K. White, Y. Dempsie, P. Caruso, E. Wallace, R.A. McDonald, and H. Stevens Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axis Hypertension 64 2014 185 194
71. A.M. Krichevsky, and G. Gabriely miR-21: a small multi-faceted RNA J Cell Mol Med 13 2009 39 53
72. Y. Cheng, P. Zhu, J. Yang, X. Liu, S. Dong, and X. Wang Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4 Cardiovasc Res 87 2010 431 439
73. P. Neth, M. Nazari-Jahantigh, A. Schober, and C. Weber MicroRNAs in flow-dependent vascular remodelling Cardiovasc Res 99 2013 294 303
74. Y.F. Li, Y. Jing, J. Hao, N.C. Frankfort, X. Zhou, and B. Shen MicroRNA-21 in the pathogenesis of acute kidney injury Protein Cell 4 2013 813 819
75. V. Patel, and L. Noureddine MicroRNAs and fibrosis Curr Opin Nephrol Hypertens 21 2012 410 416
76. S.S. Pullamsetti, C. Doebele, A. Fischer, R. Savai, B. Kojonazarov, and B.K. Dahal Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension Am J Respir Crit Care Med 185 2012 409 419
77. M. Xin, E.M. Small, L.B. Sutherland, X. Qi, J. McAnally, and C.F. Plato MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury Genes Dev 23 2009 2166 2178
78. L. Elia, M. Quintavalle, J. Zhang, R. Contu, L. Cossu, and M.V. Latronico The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease Cell Death Diff 16 2009 1590 1598
79. E. Hergenreider, S. Heydt, K. Treguer, T. Boettger, A.J. Horrevoets, and A.M. Zeiher Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs Nature Cell Biol 14 2012 249 256
80. M.E. Mayorga, and M.S. Penn miR-145 is differentially regulated by TGF-beta1 and ischaemia and targets Disabled-2 expression and wnt/beta-catenin activity J Cell Mol Med 16 2012 1106 1113
81. B. Hu, J.T. Song, H.Y. Qu, C.L. Bi, X.Z. Huang, and X.X. Liu Mechanical stretch suppresses microRNA-145 Expression by activating extracellular signal-regulated kinase 1/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotype PloS One 9 2014 e96338
82. J.M. Boucher, S.M. Peterson, S. Urs, C. Zhang, and L. Liaw The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells J Biol Chem 286 2011 28312 28321
83. B.N. Davis-Dusenbery, M.C. Chan, K.E. Reno, A.S. Weisman, M.D. Layne, and G. Lagna Down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4 J Biol Chem 286 2011 28097 28110
84. Y. Liu, S. Sinha, O.G. McDonald, Y. Shang, M.H. Hoofnagle, and G.K. Owens Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression J Biol Chem 280 2005 9719 9727
85. D.T. Wang, Z.L. Ma, Y.L. Li, Y.Q. Wang, B.T. Zhao, and J.L. Wei miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis Oncol Rep 30 2013 492 498
86. N. Zhang, X. Wei, and L. Xu miR-150 promotes the proliferation of lung cancer cells by targeting P53 FEBS Lett 587 2013 2346 2351
87. T. Weng, A. Mishra, Y. Guo, Y. Wang, L. Su, and C. Huang Regulation of lung surfactant secretion by microRNA-150 Biochem Biophys Res Commun 422 2012 586 589
88. J. Novak, P. Kruzliak, J. Bienertova-Vasku, O. Slaby, and M. Novak MicroRNA-206: a promising theranostic marker Theranostics 4 2014 119 133
89. Y.C. Chan, J. Banerjee, S.Y. Choi, and C.K. Sen miR-210: the master hypoxamir Microcirculation 19 2012 215 223
90. L. Hong, Y. Han, H. Zhang, Q. Zhao, and Y. Qiao miR-210: a therapeutic target in cancer Expert Opin Ther Targets 17 2013 21 28
91. P. Flicek, M.R. Amode, D. Barrell, K. Beal, K. Billis, and S. Brent Ensembl 2014 Nucleic Acids Res 42 2014 D749 D755
92. A. Kozomara, and S. Griffiths-Jones miRBase: annotating high confidence microRNAs using deep sequencing data Nucleic Acids Res 42 2014 D68 D73
93. Y. Dempsie, and M.R. MacLean The influence of gender on the development of pulmonary arterial hypertension Exp Physiol 98 2013 1257 1261
94. R. Mayeux Biomarkers: potential uses and limitations NeuroRx 1 2004 182 188
95. A. Zernecke, K. Bidzhekov, H. Noels, E. Shagdarsuren, L. Gan, and B. Denecke Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection Sci Signal 2 2009 ra81
96. M.P. Hunter, N. Ismail, X. Zhang, B.D. Aguda, E.J. Lee, and L. Yu Detection of microRNA expression in human peripheral blood microvesicles PLoS One 3 2008 e3694
97. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nature Cell Biol 9 2007 654 659
98. J.D. Arroyo, J.R. Chevillet, E.M. Kroh, I.K. Ruf, C.C. Pritchard, and D.F. Gibson Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Proc Natl Acad Sci U S A 108 2011 5003 5008
99. X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, and K. Wang Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res 18 2008 997 1006
100. X. Ji, R. Takahashi, Y. Hiura, G. Hirokawa, Y. Fukushima, and N. Iwai Plasma miR-208 as a biomarker of myocardial injury Clin Chem 55 2009 1944 1949
101. P. Diehl, A. Fricke, L. Sander, J. Stamm, N. Bassler, and N. Htun Microparticles: major transport vehicles for distinct microRNAs in circulation Cardiovasc Res 93 2012 633 644
102. J. Wagner, M. Riwanto, C. Besler, A. Knau, S. Fichtlscherer, and T. Roxe Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs Arterioscler Thromb Vasc Biol 33 2013 1392 1400
103. M. Mayr, A. Zampetaki, P. Willeit, J. Willeit, and S. Kiechl MicroRNAs within the continuum of postgenomics biomarker discovery Arterioscler Thromb Vasc Biol 33 2013 206 214
104. A. Zampetaki, and M. Mayr Analytical challenges and technical limitations in assessing circulating miRNAs Thromb Haemost 108 2012 592 598
105. K. Schlosser, R.J. White, and D.J. Stewart miR-26a linked to pulmonary hypertension by global assessment of circulating extracellular microRNAs Am J Respir Crit Care Med 188 2013 1472 1475
106. R.A. McDonald, A. Hata, M.R. MacLean, N.W. Morrell, and A.H. Baker MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling Cardiovasc Res 93 2012 594 604
107. E.N. Olson MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease Sci Transl Med 6 2014 239ps3
108. J. Kim Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension Mol Cells 37 2014 196 201
109. M. Garofalo, and C.M. Croce MicroRNAs as therapeutic targets in chemoresistance Drug Resist Updat 16 2013 47 59
110. M. Brock, V.J. Samillan, M. Trenkmann, C. Schwarzwald, S. Ulrich, and R.E. Gay AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension Eur Heart J 35 2014 3203 3211
111. C. Liebetrau, H. Mollmann, O. Dorr, S. Szardien, C. Troidl, and M. Willmer Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy J Am Coll Cardiol 62 2013 992 998